July 9, 2010
Two implants coming soon.
Like a double-barrel shotgun-o-flechettes to the face, news about two different types of implants is going to have some borg-wannabes salivating in anticipation. Stay cool, mensch-machines, these implant aren’t on the market… yet. But with news like this, it can give those who want… and need… them much hope.
Progress report on the artificial pancreas shows… IT WORKS.
Source: Singularity Hub
Update: It looks like Jeffrey Brewer’s dream of outfitting diabetics with artificial pancreases is coming true. A report at a recent diabetes symposium in Florida showed a vast improvement in glucose-control was achieved using the artificial pancreas:
(JDRF website) Today (27-Jun-2010), during the joint American Diabetes Association-JDRF symposium, Hovorka outlined results of his most recent study, which showed these benefits remain consistent even after adults with type 1 eat a large meal and drink a glass of white wine before bedtime. The study found that using the artificial pancreas system, these adults spent 70 percent of their time within their target blood glucose range, up from 47 percent of the time they spend within target overnight without use of the artificial pancreas system. As in the other studies, time spent in hypoglycemia tended to be reduced, even though alcohol is known to increase the risk of nocturnal/next morning hypoglycemia for people with type 1 diabetes.
Also revealed were the results of research of people who used continuous glucose monitoring, or CGM, a key component of the artificial pancreas. Those who actually used CGM and understood what its data meant had better results.
“There needs to be attention paid to the people using CGM,” she said. “We can’t just focus on the technology. In determining individualized patient care, it’s important to pay attention to who is most likely to succeed with this technology. It’s not for everybody.”
The JDRF has also set up a website, The JDRF Artificial Pancreas Project, so we can track the progress of its development. This may be a diabetic’s best chance for a cure… until they figure out a way to clone a new pancreas.
Eye telescope implant approved by the FDA
Source: CBC News
The FDA sees what they did. America’s Food and Drug Administration (the FDA) has approved a telescope implant device made by VisionCare Ophthalmic Technologies Inc. The implant is being made for senior citizens suffering from severe loss of vision due to blind spots. This is good news for seniors, but the approval comes with some drawbacks (in other words, the implants are “release candidates”)…
VisionCare needs to keep tabs on those who have already been implanted while implanting and studying a larger group of people. The implants themselves aren’t perfect, requiring rehabilitation to use them properly since only one eye can be implanted. And the implants themselves may require a cornea transplant.
Then there’s the biggest drawback: A $15K US price tag…